- Display 45 Products per page
Published: May 20, 2014 | Price: $995.00 – $1,990.00
Recent Biotech Funding, Deals and Partnerships Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years, and 2013 saw a notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this influx of corporate capital, biotechnology companies have seen a significant influx...Published: May 14, 2014 | Price: $995.00 – $1,990.00
Medical Device Markets in The Middle East Device makers are looking for fast-growing emerging markets for new sales opportunities. The Middle East, as demonstrated in this Kalorama study, offers a higher growth rate than the average for device markets in the world. This study concentrates on the medical device market in the Middle East (ME). In this report, market size and forecasts are provided for the following countries: Israel Iran Saudi Arabia UAE Jordan Other Middle East Markets For each...Published: May 7, 2014 | Price: $995.00 – $1,990.00
Healthcare Associated Infection (HAI) Control Markets: Disinfection, Area, Sterilization, Device Sterilization, Testing-C.diff, Testing-MRSA, Treatments Infections from activities and procedures taking place within a healthcare facility have become a cause for great concern. These infection may occur in a postoperative wound or as a complication unrelated to the disease or condition. This report, Healthcare-Associated Infection (HAI) Control Markets: focuses on the market opportunities for companies that can assist hospitals and other healthcare facilities with important HAI mitigation tasks including: preventing, testing...Published: April 30, 2014 | Price: $995.00 – $1,990.00
For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments. Chemistry Services Market: Building Blocks, Compound Synthesis, Libraries,...Published: April 29, 2014 | Price: $1,995.00 – $3,990.00
For capacity, accuracy, and specificity of analysis, the use of mass spectrometry in clinical diagnostics and clinical research has grown dramatically in recent years. This Kalorama Information report, Mass Spectrometry for Clinical Applications: Market Analysis and End User Survey, looks at the growth of Mass Spec systems being used in diagnostics and other clinical applications this year. A Detailed Examination of the Market Opportunity for MS in Clinical Applications Prior to the explosion in the last several years, GC-MS, LC-MS,...Published: April 21, 2014 | Price: $995.00 – $1,990.00
Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The Kalorama information report examines the global market for vaccines, covering specifically commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable. Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission....Published: April 16, 2014 | Price: $600.00 – $1,200.00
Results of the 2014 (Jan-Feb 2014) survey of glucose meter users.Published: April 7, 2014 | Price: $500.00 – $1,000.00
Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 Kalorama Information's Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2023 takes a considered look at the pharmaceutical industry, including the late-term pipeline of major companies. This report provides long-term company sales forecasts based recent market conditions. For each company, the report provides: Revenues R&D Spending Geographic Breakout of Revenues Performance of Specific Products Performance by Drug Category Late-Stage Pipeline Projections of Revenues to 2023 In addition...Published: April 2, 2014 | Price: $995.00 – $1,990.00
The EMR Industry Standard Kalorama has continuously examined the fast-changing market for electronic medical records (EMR) for nearly a decade, and each year we produce a comprehensive report of our findings. Our report has become the industry standard, oft-quoted by companies and industry associations as the source for market sizing and market share in healthcare. This Kalorama Information report, EMR 2014, is a complete global analysis of the EMR market. The report includes the important trends that will affect companies offering software, hardware and services related to EMR....Published: March 18, 2014 | Price: $1,995.00 – $3,990.00
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments...Published: March 11, 2014 | Price: $750.00 – $1,500.00
Retail Clinics Market Overview and 2014 Survey Results Retail clinics are medical settings located in a retail store. They are not free standing and do not offer all medical services. Yet they provide an option for busy Americans seeking a convenient option for basic healthcare needs such as vaccinations or cold remedies. Kalorama Information has published several studies on retail clinics since 2007. Over the past few years, we have analyzed the economic performance of stores and opportunities for suppliers....Published: February 27, 2014 | Price: $995.00 – $1,990.00
The Long Term Care Market, Forecasts to 2018 The advancing age of the population makes long-term care an important consideration for health marketers. This report, The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living, covers the most important segments of the long term care industry, each of which provide medical care and/or assistance with the activities of daily living (ADLs) on an ongoing basis: Nursing care Home care Hospice care Assisted living ...Published: February 22, 2014 | Price: $995.00 – $1,990.00
This unique report, Surgical Procedure Volumes Global Analysis, is an essential tool for healthcare business planners. The report provides surgical procedure volume data in a geographic context. The report looks at surgery trends with an in-depth analysis of growth drivers and inhibitors, including world population growth, aging demographics, lifestyle indicators, growing incidence of diseases, advances in surgical techniques and several other general issues affecting the forecast for procedures. The report details these procedure trends globally, and then has specific analysis for...Published: February 11, 2014 | Price: $995.00 – $1,990.00
The Market for Medical Devices in EMEA For makers of medical devices, the European, Middle Eastern and African (EMEA) economies represent significant opportunities. This report as part of its coverage concentrates on the EMEA medical device industries and estimates the business in specific device categories. For the following countries and regions, the report contains specific device business estimates: Israel Iran UAE Jordan Saudi Arabia South Africa Egypt Europe Africa Middle East Germany France UK Italy Other Europe Highly competitive in...Published: February 5, 2014 | Price: $2,995.00 – $5,990.00
The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products. A good number of companies are producing or...Published: February 5, 2014 | Price: $1,995.00 – $3,990.00
Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others) Medical imaging’s contributions to medical practice has made it an ever-growing industry with new technologies constantly being launched. Early and more accurate diagnoses are made possible via imaging scans, which in turn may lead to optimized treatment regimens. The Medical Imaging Markets report reviews current and potential world opportunities for medical imaging systems, which include x-ray, mammography, fluoroscopy, CT, MRI, Ultrasound, PET and SPECT, and fusion systems. This study forecasts...Published: February 5, 2014 | Price: $1,995.00 – $3,995.00
IVD manufacturers on the lookout for growth have targeted the Philippines among other places. Expanding economies worldwide need to increase healthcare spending to satisfy growing middle and low-to-middle class populations. IVD performs where healthcare spending increases as it is often the entry point of healthcare. This report, IVD Distribution in The Philippines, reviews the distribution of in vitro diagnostic products in this growing Asian Market. IVD in the Philippines includes: What Products Lines Are Distributed by Which Philippine IVD Companies...Published: January 23, 2014 | Price: $995.00 – $1,990.00
Next-Generation Sequencing in Latin America This report is an examination of the use of DNA sequencing systems in the Latin American region, based on a survey conducted in Fall 2013 by VA Consultadoros. The survey centered on instrumentation, with a goal of providing a complete count of next-generation sequencing (NGS) systems sold to customers in the major countries of Latin American. For the healthcare industry, Latin America is a focus. The region went through its highest economic growth period in...Published: January 23, 2014 | Price: $995.00 – $1,990.00
The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement) Despite economic downturns mainly owing to the aging of the world population and the increasing incidence of chronic obstructive pulmonary disease (COPD), the worldwide respiratory device industry continues to increase. The business comprises many different offerings to treat and track respiratory conditions as well as many large and small manufacturers. This Kalorama report contains exhaustive business coverage, including estimates and forecasts...Published: January 14, 2014 | Price: $995.00 – $1,990.00
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology. In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular...Published: January 6, 2014 | Price: $995.00 – $1,990.00
The Worldwide Market for Infusion Pumps The Worldwide Market for Infusion Pumps contains Kalorama Information's most complete research into infusion pump devices used for patient treatment and nutrition. This device is a high-interest area for several companies, given the aging of the population and the increased need for services in the healthcare area. The report outlines the important types of infusion pumps, projects sales and discusses the key competitors that make and offer pumps for sale. This report classifies two...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: December 20, 2013 | Price: $3,995.00 – $7,990.00
The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. Clinical Laboratory Services...Published: December 16, 2013 | Price: $995.00 – $1,990.00
Full coverage of the IVD market in Mexico, including important IVD segments.Published: December 11, 2013 | Price: $995.00 – $1,990.00
This report, The World Market for Implantable and Needle-Free Drug Delivery details the types of drug delivery systems and technologies that are being used in 2012, as well as those that may become major market factors by the end of the forecast period. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report's market analysis encompasses drug delivery technology and the revenues earned from licensing that technology. Secondly, it encompasses the...Published: November 22, 2013 | Price: $1,995.00 – $4,000.00
The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by Kalorama Analyst Emil Salazar, defines the market worldwide for analyzers, point of care tests, stains and slides and imaging systems used in hematology testing. Hematology...Published: November 8, 2013 | Price: $1,995.00 – $4,000.00
The medical beds industry remains diverse and highly competitive. The growing demand for highly functional and less expensive products is paramount in the market. This Kalorama Information report, The World Market for Medical Beds provides those watching the medical device markets with an overview of the medical beds industry and the trends driving growth. Medical beds include all hospital types of beds including mattresses and overlays. Included in the report are statistics influencing the industry, incidence of diseases worldwide, demographics;...Published: November 8, 2013 | Price: $3,995.00 – $7,990.00
Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) Kalorama Information’s Wireless Opportunities in Healthcare (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies) is a complete guide to the fast-growing market for wireless healthcare applications in the United States and globally. This report contains explanations that cut through the confusion surrounding these technologies and provide readers with a total picture of wireless in healthcare. It makes market...Published: November 6, 2013 | Price: $3,995.00 – $7,990.00
The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...Published: October 25, 2013 | Price: $1,995.00 – $3,900.00
What is the procedure, for establishing reimbursement for an IVD test product? What companies have been successful and how? What changes will IVD makers face in the near-term. This Kalorama Information report, Reimbursement for In Vitro Diagnostic Tests, answers these questions and provides authoritative data for IVD business planners. One of the critical factors for the success of an IVD product is reimbursement. Reimbursement is a critical component of the health care landscape and will continue to have a major...Published: October 21, 2013 | Price: $3,995.00 – $7,990.00
Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats. One of the Most Dynamic Areas of the...Published: October 16, 2013 | Price: $3,995.00 – $7,990.00
The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine. Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase,...Published: September 22, 2013 | Price: $2,995.00 – $6,000.00
The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used by select worldwide generic companies in exploring the emerging area of biosimilars, the issues and trends that are shaping the marketplace, and the potential feasibility of providing biosimilars within the United States regulatory environment....Published: September 19, 2013 | Price: $2,500.00 – $5,000.00
Laboratory Information Systems (LIS / LIMS) Markets (Clinical Laboratory Software and Hardware, Drug Discovery Systems) Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. This Kalorama Information market report, The World Market for Lab Information Systems (LIS) analyzes the current and potential world markets for medical laboratory information system software and hardware -- both for the clinical diagnostics lab and...Published: September 13, 2013 | Price: $50.00 – $100.00
The medical device tax that took effect Jan. 1, 2013 for all manufacturers of Class I, Class II and Class III devices in the United States may have had an impact on device company spending, according to this complimentary Public Policy Paper from Kalorama Information. While the tax was in effect in the 2012 year, the paper looks at budgeted R&D spending as companies anticipated new costs from the program. The conclusions are the result of information from Kalorama Information's...Published: September 13, 2013 | Price: $1,500.00 – $3,000.00
Brazil is the fifth largest country in the world, after Russia, Canada, China and the United States. The size of the country as made it a focus for IVD companies. This report, The IVD Market in Brazil, provides market estimates and forecasts for the main categories of in vitro diagnostics, and forecasts those markets to 2017. Information was obtained by both primary and secondary sources. Annual reports, trade publications, as well as telephone and email surveys of IVD manufacturers operating...Published: September 10, 2013 | Price: $995.00 – $1,990.00
The World Market for Cloud Computing in Healthcare Healthcare providers around the world are facing rising costs while they attempt to maintain or improve care. Healthcare information technology (HIT) is a key component of streamlining healthcare in a way that can provide benefits to those involved. As this report details, cloud computing is a way of using existing technology to modernize the healthcare industry. Cloud technologies are generally off-site, third-party-managed computing resources that can include computational resources, additional data storage...Published: August 21, 2013 | Price: $2,500.00 – $5,000.00
This report, The World Market for Minimally Invasive Surgical Devices, includes product information, procedure volume data, world demographics, and other general issues affecting the MIS device market. Minimally invasive surgery (MIS) currently allows doctors to perform many complicated operations with a short hospital stay, better patient satisfaction and outcomes. The concept has driven the growth of devices for minimally invasive procedures. In this report, a detailed market analysis includes six general surgery areas reflecting revenues earned by all manufacturers in...Published: August 16, 2013 | Price: $995.00 – $1,995.00
The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry The "Patient Protection and Affordable Care Act" (H.R. 3590) is complex legislation that affects virtually every aspect of health care, and many of its provisions are beginning to take effect now. IVD manufacturers who have different needs and strategies are now considering the legislation and whether it will help or hurt business plans. The legislation contains a range of different provisions and while the law in a broad sense...Published: August 15, 2013 | Price: $3,995.00 – $7,990.00
The Market for Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Circulating tumor cells (CTCs) are believed to detach from primary or secondary tumors and enter the bloodstream, traveling to distant organs and forming new tumors. These cells that leave the primary tumor are able to colonize distant organs in the body and initiate the process of metastasis; however, their biology is still not entirely elucidated. Circulating tumor cells have tremendous utility in cancer research, aiding scientists in deciphering...Published: August 9, 2013 | Price: $3,995.00 – $7,990.00
This Kalorama Information report The Market for Hospital-Acquired Infection Control (Sterilization, Cleaning, Testing, Treatment) focuses on the market for preventing, testing and treating infections in the healthcare environment. Given the cost of hospital-acquired and healthcare-associated infections (HAIs), demand has increased for solutions that can help the healthcare industry reduce infections and the costs associated with them. The U.S. Centers for Disease Control and Prevention (CDC) estimates that around 1 in 20 or 5% of hospitalized patients will contract an HAI. ...Published: August 5, 2013 | Price: $1,995.00 – $3,990.00
Australia represents a highly competitive IVD market with established international players, a highly developed export-intensive domestic industry, and highly consolidated clinical lab and testing industry. While other developed IVD markets in North America, Europe and Japan are not estimated to be achieving above 3% annual growth, the Australian IVD market has grown at an average of roughly 5% through the past five years. This rate of growth is projected to more or less continue with a stable funding environment through...Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...Published: August 1, 2013 | Price: $4,200.00 – $8,400.00
Lateral flow tests, also known as immunochromatographic strip (ICS) tests, are point of care tests that reduce the time spent waiting for test results from hours to minutes, require less training for operators, and reduce the cost of both device development and care. This report, Lateral Flow Technology and the Future of Point of Care Testing, 2nd Edition, takes an in depth look at the market, technologies, and trends in lateral flow point-of-care testing, looking at both self-testing by patients...Published: July 1, 2013 | Price: $1,500.00 – $3,000.00
Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course of doing this, the report seeks to answer the following questions: What is the status of clinical applications for Next Gen in laboratories currently? What...